Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.050
+0.030 (1.49%)
Mar 18, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 381.75 million as of March 18, 2026. Its market cap has decreased by -38.18% in one year.
Market Cap
381.75M
Enterprise Value
674.19M
Revenue
737.49M
Ranking
n/a
PE Ratio
14.33
Stock Price
2.05
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 381.75M, a decrease of -44.70%. That is a compound annual growth rate of -11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 387.02M | -26.28% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.23B |
| Integral Diagnostics | 867.57M |
| Healius | 428.42M |
| Monash IVF Group | 249.37M |
| Rhythm Biosciences | 68.92M |
| Cryosite | 58.33M |
| Microba Life Sciences | 48.72M |
| INOVIQ | 47.16M |